Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Av. Morones Prieto 3000, Monterrey 64710, N.L., Mexico.
Molecules. 2021 Nov 20;26(22):7026. doi: 10.3390/molecules26227026.
Early detection is a key factor in patient fate. Currently, multiple biomolecules have been recognized as biomarkers. Nevertheless, their identification is only the starting line on the way to their implementation in disease diagnosis. Although blood is the biofluid par excellence for the quantification of biomarkers, its extraction is uncomfortable and painful for many patients. In this sense, there is a gap in which saliva emerges as a non-invasive and valuable source of information, as it contains many of the biomarkers found in blood. Recent technological advances have made it possible to detect and quantify biomarkers in saliva samples. However, there are opportunity areas in terms of cost and complexity, which could be solved using simpler methodologies such as those based on enzymes. Many reviews have focused on presenting the state-of-the-art in identifying biomarkers in saliva samples. However, just a few of them provide critical analysis of technical elements for biomarker quantification in enzymatic methods for large-scale clinical applications. Thus, this review proposes enzymatic assays as a cost-effective alternative to overcome the limitations of current methods for the quantification of biomarkers in saliva, highlighting the technical and operational considerations necessary for sampling, method development, optimization, and validation.
早期检测是影响患者预后的关键因素。目前,已有多种生物分子被确认为生物标志物。然而,它们的鉴定仅仅是将其应用于疾病诊断的起点。尽管血液是定量生物标志物的首选生物流体,但对许多患者来说,采集血液非常不舒服和痛苦。在这方面,存在一个空白,唾液作为一种非侵入性和有价值的信息来源出现了,因为它包含了许多在血液中发现的生物标志物。最近的技术进步使得在唾液样本中检测和定量生物标志物成为可能。然而,在成本和复杂性方面仍存在一些机会,这些问题可以通过使用更简单的方法来解决,例如基于酶的方法。许多综述都集中在介绍唾液样本中生物标志物识别的最新技术。然而,只有少数综述对酶法用于大规模临床应用的生物标志物定量的技术要素进行了批判性分析。因此,本综述提出了酶法测定作为一种具有成本效益的替代方法,以克服目前唾液中生物标志物定量方法的局限性,强调了采样、方法开发、优化和验证所需的技术和操作考虑因素。